17-38352554-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014598.4(SOCS7):āc.502G>Cā(p.Gly168Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000503 in 1,549,508 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00037 ( 0 hom., cov: 33)
Exomes š: 0.00052 ( 1 hom. )
Consequence
SOCS7
NM_014598.4 missense
NM_014598.4 missense
Scores
2
2
11
Clinical Significance
Conservation
PhyloP100: 0.575
Genes affected
SOCS7 (HGNC:29846): (suppressor of cytokine signaling 7) Predicted to enable 1-phosphatidylinositol-3-kinase regulator activity. Predicted to be involved in phosphatidylinositol phosphate biosynthetic process. Predicted to act upstream of or within several processes, including brain development; fat cell differentiation; and insulin receptor signaling pathway. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.11039576).
BS2
High AC in GnomAd4 at 57 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOCS7 | NM_014598.4 | c.502G>C | p.Gly168Arg | missense_variant | 1/10 | ENST00000612932.6 | NP_055413.2 | |
SOCS7 | XM_017024551.2 | c.502G>C | p.Gly168Arg | missense_variant | 1/9 | XP_016880040.1 | ||
SOCS7 | XM_017024552.2 | c.502G>C | p.Gly168Arg | missense_variant | 1/8 | XP_016880041.1 | ||
SOCS7 | XR_007065295.1 | n.711G>C | non_coding_transcript_exon_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOCS7 | ENST00000612932.6 | c.502G>C | p.Gly168Arg | missense_variant | 1/10 | 1 | NM_014598.4 | ENSP00000482229.2 | ||
SOCS7 | ENST00000665913.1 | c.310G>C | p.Gly104Arg | missense_variant | 1/10 | ENSP00000499750.1 | ||||
SOCS7 | ENST00000613678.5 | c.325G>C | p.Gly109Arg | missense_variant | 1/9 | 5 | ENSP00000484381.2 | |||
SOCS7 | ENST00000617360.1 | n.4G>C | non_coding_transcript_exon_variant | 1/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 152194Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
57
AN:
152194
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000343 AC: 49AN: 142962Hom.: 0 AF XY: 0.000298 AC XY: 23AN XY: 77192
GnomAD3 exomes
AF:
AC:
49
AN:
142962
Hom.:
AF XY:
AC XY:
23
AN XY:
77192
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000517 AC: 722AN: 1397198Hom.: 1 Cov.: 33 AF XY: 0.000515 AC XY: 355AN XY: 689026
GnomAD4 exome
AF:
AC:
722
AN:
1397198
Hom.:
Cov.:
33
AF XY:
AC XY:
355
AN XY:
689026
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000374 AC: 57AN: 152310Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74482
GnomAD4 genome
AF:
AC:
57
AN:
152310
Hom.:
Cov.:
33
AF XY:
AC XY:
21
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.310G>C (p.G104R) alteration is located in exon 1 (coding exon 1) of the SOCS7 gene. This alteration results from a G to C substitution at nucleotide position 310, causing the glycine (G) at amino acid position 104 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L
PrimateAI
Pathogenic
D
Sift4G
Uncertain
D;D
Polyphen
0.33
.;B
Vest4
MutPred
Gain of helix (P = 0.0496);Gain of helix (P = 0.0496);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at